Coronary artery disease risk among obese metabolically healthy young men

European Journal of Endocrinology

Volumn 173, Issue 3, 2015, Pages 305-312

  Twig, Gilad ^a,b   Gerstein, Hertzel C ^c   Shor, Dana Ben Ami ^a   Derazne, Estela ^b,d   Tzur, Dorit ^b   Afek, Arnon ^d,e   Tirosh, Amir ^a,f  

^a SHEBA MEDICAL CENTER   (Israel)

^b MEDICAL CORPS   (Israel)

^c HAMILTON HEALTH SCIENCES   (Canada)

^d TEL AVIV UNIVERSITY   (Israel)

^e MINISTRY OF HEALTH   (Israel)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE ASSESSMENT; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; INCIDENCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; METABOLIC LIFESTYLE AND NUTRITION ASSESSMENT IN YOUNG ADULT; OBESITY; PRIORITY JOURNAL; RISK ASSESSMENT; BLOOD; MULTIVARIATE ANALYSIS; OVERWEIGHT; PROPORTIONAL HAZARDS MODEL;

ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; CHOLESTEROL, HDL; COHORT STUDIES; CORONARY ARTERY DISEASE; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MULTIVARIATE ANALYSIS; OBESITY; OVERWEIGHT; PROPORTIONAL HAZARDS MODELS; TRIGLYCERIDES;

EID: 84940668483     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-15-0284     Document Type: Article

References (36)

1. Tirosh A, Shai I, Afek A, Dubnov-Raz G, Ayalon N, Gordon B, Derazne E, Tzur D, Shamis A, Vinker S et al. Adolescent BMI trajectory and risk of diabetes versus coronary disease. New England Journal of Medicine 2011 364 1315-1325. (doi:10.1056/NEJMoa1006992)
2. Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, Lang CC, Rumboldt Z, Onen CL, Lisheng L et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 2005 366 1640-1649. (doi:10.1016/S0140-6736(05)67663-5)
3. Kramer CK, Zinman B & Retnakaran R. Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysis Annals of Internal Medicine 2013 159 758-769. (doi:10.7326/0003-4819-159-11-201312030-00008)
4. Roberson LL, Aneni EC, Maziak W, Agatston A, Feldman T, Rouseff M, Tran T, BlahaMJ, Santos RD, Sposito A et al. The "Metabolically healthy obese" phenotype & its association with clinical/subclinical cardiovascular disease and all-cause mortality - a systematic review. BMC Public Health 2014 14 14. (doi:10.1186/1471-2458-14-14)
5. Stefan N, Haring HU, Hu FB & Schulze MB. Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet. Diabetes & Endocrinology 2013 1 152-162. (doi:10.1016/S2213-8587(13)70062-7)
6. Hosseinpanah F, Barzin M, Sheikholeslami F & Azizi F. Effect of different obesity phenotypes on cardiovascular events in Tehran Lipid and Glucose Study (TLGS). American Journal of Cardiology 2011 107 412-416. (doi:10.1016/j.amjcard.2010.09.034)
7. Kuk JL & Ardern CI. Are metabolically normal but obese individuals at lower risk for all-cause mortality? Diabetes Care 2009 32 2297-2299. (doi:10.2337/dc09-0574)
8. Song Y, Manson JE,Meigs JB, Ridker PM, Buring JE & Liu S. Comparison of usefulness of body mass index versus metabolic risk factors in predicting 10-year risk of cardiovascular events in women. American Journal of Cardiology 2007 100 1654-1658. (doi:10.1016/j.amjcard. 2007.06.073)
9. Meigs JB, Wilson PW, Fox CS, Vasan RS, Nathan DM, Sullivan LM & D'Agostino RB. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. Journal of Clinical Endocrinology and Metabolism 2006 91 2906-2912. (doi:10.1210/jc.2006-0594)
10. Hinnouho GM, Czernichow S, Dugravot A, Nabi H, Brunner EJ, Kivimaki M & Singh-Manoux A. Metabolically healthy obesity and the risk of cardiovascular disease and type 2 diabetes: the Whitehall II cohort study. European Heart Journal 2015 36 551-559. (doi:10.1093/eurheartj/ehu123)
11. Arnlov J, Ingelsson E, Sundstrom J & Lind L. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation 2010 121 230-236. (doi:10.1161/CIRCULATIONAHA.109.887521)
12. Ford ES & Capewell S. Coronary heart disease mortality among young adults in the U.S. from 1980 through 2002: concealed leveling of mortality rates. Journal of the American College of Cardiology 2007 50 2128-2132. (doi:10.1016/j.jacc.2007.05.056)
13. O'Flaherty M, Allender S, Taylor R, Stevenson C, Peeters A & Capewell S. The decline in coronary heart disease mortality is slowing in young adults (Australia 1976-2006): a time trend analysis. International Journal of Cardiology 2012 158 193-198. (doi:10.1016/j.ijcard.2011. 01.016)
14. Twig G, Afek A, Shamiss A,Derazne E, Landau Rabbi M, Tzur D, Gordon B & Tirosh A. Adolescence BMI and trends in adulthood mortality: a study of 2.16 million adolescents. Journal of Clinical Endocrinology and Metabolism 2014 99 2095-2103. (doi:10.1210/jc.2014-1213)
15. Tirosh A, Shai I, Tekes-Manova D, Israeli E, Pereg D, Shochat T, Kochba I & Rudich A. Normal fasting plasma glucose levels and type 2 diabetes in young men. New England Journal of Medicine 2005 353 1454-1462. (doi:10.1056/NEJMoa050080)
16. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Journal of the American Medical Association 2001 285 2486-2497. (doi:10.1001/jama.285.19.2486)
17. Twig G, Afek A, Shamiss A, Derazne E, Tzur D, Gordon B & Tirosh A. White blood cell count and the risk for coronary artery disease in young adults. PLoS ONE 2012 7 e47183. (doi:10.1371/journal.pone.0047183)
18. Tirosh A, Rudich A, Shochat T, Tekes-Manova D, Israeli E, Henkin Y, Kochba I & Shai I. Changes in triglyceride levels and risk for coronary heart disease in young men. Annals of Internal Medicine 2007 147 377-385. (doi:10.7326/0003-4819-147-6-200709180-00007)
19. Appleton SL, Seaborn CJ, Visvanathan R, Hill CL, Gill TK, Taylor AW & Adams RJ. Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study. Diabetes Care 2013 36 2388-2394. (doi:10.2337/dc12-1971)
20. Aung K, Lorenzo C, Hinojosa MA & Haffner SM. Risk of developing diabetes and cardiovascular disease in metabolically unhealthy normal-weight and metabolically healthy obese individuals. Journal of Clinical Endocrinology and Metabolism 2014 99 462-468. (doi:10.1210/jc.2013-2832)
21. Kip KE, Marroquin OC, Kelley DE, Johnson BD, Kelsey SF, Shaw LJ, Rogers WJ & Reis SE. Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study. Circulation 2004 109 706-713. (doi:10.1161/01.CIR.0000115514.44135.A8)
22. Hamer M & Stamatakis E. Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. Journal of Clinical Endocrinology and Metabolism 2012 97 2482-2488. (doi:10.1210/jc.2011-3475)
23. St-Pierre AC, Cantin B, Mauriege P, Bergeron J, Dagenais GR, Despres JP & Lamarche B. Insulin resistance syndrome, body mass index and the risk of ischemic heart disease. CMAJ: Canadian Medical Association Journal 2005 172 1301-1305. (doi:10.1503/cmaj.1040834)
24. Calori G, Lattuada G, Piemonti L, Garancini MP, Ragogna F, Villa M, Mannino S, Crosignani P, Bosi E, Luzi L et al. Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study. Diabetes Care 2011 34 210-215. (doi:10.2337/dc10-0665)
25. Bobbioni-Harsch E, Pataky Z, Makoundou V, Laville M, Disse E, Anderwald C, Konrad T & Golay A. From metabolic normality to cardiometabolic risk factors in subjects with obesity. Obesity 2012 20 2063-2069. (doi:10.1038/oby.2012.69)
26. Bell JA, Hamer M, Sabia S, Singh-Manoux A, Batty GD & Kivimaki M. The natural course of healthy obesity over 20 years. Journal of the American College of Cardiology 2015 65 101-102. (doi:10.1016/j.jacc. 2014.09.077)
27. Sinaiko AR, Donahue RP, Jacobs DR Jr & Prineas RJ. Relation of weight and rate of increase in weight during childhood and adolescence to body size, blood pressure, fasting insulin, and lipids in young adults. The Minneapolis Children's Blood Pressure Study. Circulation 1999 99 1471-1476. (doi:10.1161/01.CIR.99.11.1471)
28. LeFevre ML. Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: U.S. Preventive Services Task Force Recommendation Statement. Annals of Internal Medicine 2014 161 587-593. (doi:10.7326/M14-1796)
29. Twig G, Afek A, Derazne E, Tzur D, Cukierman-Yaffe T, Gerstein HC & Tirosh A. Diabetes risk among overweight and obese metabolically healthy young adults. Diabetes Care 2014 37 2989-2995. (doi:10.2337/dc14-0869)
30. Vassy JL, Hivert MF, Porneala B, Dauriz M, Florez JC, Dupuis J, Siscovick DS, Fornage M, Rasmussen-Torvik LJ, Bouchard C et al. Polygenic type 2 diabetes prediction at the limit of common variant detection. Diabetes 2014 63 2172-2182. (doi:10.2337/db13-1663)
31. Nguyen QM, Srinivasan SR, Xu JH, Chen W, Hassig S, Rice J & Berenson GS. Elevated liver function enzymes are related to the development of prediabetes and type 2 diabetes in younger adults: the Bogalusa Heart Study. Diabetes Care 2011 34 2603-2607. (doi:10.2337/dc11-0919)
32. Wurtz P, Soininen P, Kangas AJ, Ronnemaa T, Lehtimaki T, Kahonen M, Viikari JS, Raitakari OT & Ala-Korpela M. Branchedchain and aromatic amino acids are predictors of insulin resistance in young adults. Diabetes Care 2013 36 648-655. (doi:10.2337/dc12-0895)
33. McLaughlin T, Lamendola C, Liu A & Abbasi F. Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity. Journal of Clinical Endocrinology and Metabolism 2011 96 E1756-E1760. (doi:10.1210/jc.2011-0615)
34. Heianza Y, Arase Y, Tsuji H, Fujihara K, Saito K, Hsieh SD, Tanaka S, Kodama S, Hara S & Sone H. Metabolically healthy obesity, presence or absence of fatty liver, and risk of type 2 diabetes in Japanese individuals: Toranomon Hospital Health Management Center Study 20 (TOPICS 20). Journal of Clinical Endocrinology and Metabolism 2014 99 2952-2960. (doi:10.1210/jc.2013-4427)
35. Ortega FB, Lee DC, Katzmarzyk PT, Ruiz JR, Sui X, Church TS & Blair SN. The intriguing metabolically healthy but obese phenotype: cardiovascular prognosis and role of fitness. European Heart Journal 2013 34 389-397. (doi:10.1093/eurheartj/ehs174)
36. Keith SW, Fontaine KR, Pajewski NM, Mehta T & Allison DB. Use of self-reported height and weight biases the body mass index-mortality association. International Journal of Obesity 2011 35 401-408. (doi:10.1038/ijo.2010.148)